Introduction {#s0001}
============

The cadherin-catenin complex is widely viewed as a linchpin of tissue cohesion and organization. This complex contains a transmembrane cadherin extracellular domain that engages an identical cadherin on adjacent cells. The cadherin cytoplasmic domain associates with catenins that either stabilize cell surface cadherins (e.g., p120^ctn^) or physically links cadherins to the underlying cytoskeleton (e.g., β-catenin and α-catenin to actin filaments; p120^ctn^ to microtubules) to bring about robust intercellular adhesion.[@cit0001]^,^[@cit0002] For historical reasons, the most well studied cadherin-catenin complex comprises cadherin and catenins typically found in epithelia across tissue types---an [E]{.ul}pithelial-cadherin (E-cadherin), paired with the more ubiquitously expressed p120^ctn^, β-catenin and "[e]{.ul}pithelial" α-catenin (αE-catenin, or αE-cat). This "canonical" cadherin-catenin complex, however, belies known gene complexity at each protein position in the cadherin-catenin complex ([Fig. 1](#f0001){ref-type="fig"}). Although fundamental paradigms of cell-cell adhesion have been gleaned from this canonical cadherin-catenin complex, expansion of the cadherin-catenin gene family evolved for a reason--- enabling cell and tissue specialization of the basic epithelial adhesive paradigm, which favors organismal fitness. In this review, we focus on one of the more recently evolved catenins, αT-catenin (αT-cat), as a means to understand how modest alterations in the cadherin-catenin adhesion system may be relevant to a range of human diseases. Figure 1.Schematic representation of cadherin-catenin complexes with distinct α-catenin isoforms αE-cat, αN-cat and αT-cat. Note that there is substantial isoform diversity at the other positions in the cadherin-catenin complex, such as ∼19 classical cadherins (i.e., catenin-binding) encompassing both type I and type II forms,[@cit0091] three p120ctns as well as the β-catenin homologue, plakoglobin (reviewed in[@cit0092]). For simplicity, these other isoforms are not shown with the exception of αE-cat participating in an E-cadherin complex, and αT-cat with an N-cadherin complex.

α-Catenins: Knock-out phenotypes reflect tissue distribution {#s0001-0001}
------------------------------------------------------------

α-Catenins are β-catenin and actin-binding proteins, where binding to both β-catenin and actin is required to directly link the cadherin complex to cortical actin filaments. They are found in nominally-defined epithelial (E), neural (N), and testis (T) forms transcribed from three distinct genes,[@cit0003] where each is sufficient to rescue cadherin-based adhesion in α-catenin-negative cell lines.[@cit0003] As is often the case with early nomenclature, formal names can be misleading now that greater resolving RNA sequencing technologies are available. In this regard, the human [g]{.ul}enotype-[t]{.ul}issue [e]{.ul}xpression (GTEx) database[@cit0007] clearly shows that αE-cat (*CTNNA1*) is not epithelial-restricted, but rather ubiquitously expressed ([Fig. 2a](#f0002){ref-type="fig"}). These data are consistent with evidence that mouse knock-outs targeting *Ctnna1* across a range of tissues can lead to penetrant loss of cell-cell adhesion/tissue organization (e.g., whole embryo,[@cit0008] skin,[@cit0009] brain[@cit0010] and heart[@cit0011]). In contrast to the ubiquity of αE-cat, αN-cat (*CTNNA2*) is largely restricted to brain ([Fig. 2b](#f0002){ref-type="fig"}), consistent with evidence that *Ctnna2* knock-out mice display hypomorphic brains and perinatal lethality.[@cit0012]^,^[@cit0013] Remarkably, the more recently evolved αT-cat (*CTNNA3*), named after its expression in the testis and best known for its role in the heart,[@cit0014] is also abundantly expressed in the brain, spinal cord, and peripheral nerve ([Fig. 2c](#f0002){ref-type="fig"}). Although *Ctnna3* knock-out mice are viable and fertile,[@cit0015] this curious tissue distribution of *CTNNA3*, together with growing linkages between *CTNNA3* and diseases compatible with this distribution (see below), raise the intriguing notion that αT-cat/*CTNNA3* may be the α-catenin most relevant to a broad range of human diseases. Figure 2.α-Catenin isoform expression analysis across human tissues. Graphs exported from the human [G]{.ul}enotype-[T]{.ul}issue [E]{.ul}xpression (GTEx) portal using *CTNNA1, CTNNA2* and *CTNNA3* gene identifiers. Expression values shown as Transcripts Per Million (TPM) calculated from a gene model with isoforms collapsed to a single gene. No other normalization steps were applied. Box plots are shown as median and 25^th^ and 75^th^ percentiles; points are displayed as outliers if they are above or below 1.5 times the interquartile range. Number of human tissue samples range from ∼100-500 per tissue and can be viewed via the portal.

αE-cat: Founding member of the α-catenin family {#s0001-0002}
-----------------------------------------------

Due to its ubiquity, molecular and structural analyses are best known for αE-cat, the subject of recent excellent reviews.[@cit0016]^,^[@cit0019]^,^[@cit0020] The prevailing view of αE-cat in the cadherin complex is as a mechanosensitive scaffold protein that features a series of six, bundled α-helical domain-regions.[@cit0021] There are two key aspects to its mechanosensitivity. First, the C-terminal F-actin binding domain of αE-cat shows preferential binding to actin filaments under tension *in vitro*,[@cit0026] suggesting that αE-cat may preferentially couple the cadherin/β-catenin complex to actin filaments that are under myosin-based cortical tension. Contractile actin structures are typically found at discreet plasma membrane locations (e.g., zonula and focal adhesions), and the precise nature of this force-activated binding event is presently unclear. Second, the [m]{.ul}iddle or M-region of αE-cat undergoes force-dependent unfurling,[@cit0023]^,^[@cit0027] exposing a cryptic site that favors recruitment of the related actin-binding protein, vinculin. In epithelia, vinculin recruitment to αE-cat occurs in regions of the plasma membrane that are under elevated forces, such as an apical adhesive zone known as the zonula adherens.[@cit0023]^,^[@cit0024] Since a number of proteins interact with αE-cat through its mechanosensitive M-region,[@cit0017]^,^[@cit0028] it is possible that some of these partners may be variably recruited to αEcat under distinct force-activated thresholds ([Fig. 3](#f0003){ref-type="fig"}). Figure 3.Mechanosensor model of αE-cat in cell-cell adhesion. The actin-binding domain (ABD) of αE-cat (green) preferentially associates with actin filaments under tension (high tension versus low tension). This leads to unfurling of the M-domain (M1), which allows vinculin binding and adherens junction reinforcement.

Given the level of amino acid identity/similarity between αE-cat and αT-cat (56.1%/73.7%) or αN-cat (76.5%/83.1%)\[3\], we may reason that these related α-catenins share an analogous mechanosensitivity. Although biochemical and cellular characterization of αN-cat and αT-cat lags behind αE-cat, recent studies suggest that cadherin complexes containing these α-catenins are indeed different. For example, αE-cat recruits vinculin to adherens junctions more effectively than αN-cat using an α-catenin negative epithelial cell line, possibly due αE-cat\'s higher affinity for actin filaments *in vitro*.[@cit0024] How such differences are leveraged by epithelia (αE-cat) and neurons (αN-cat) to suit their respective junction-coupling needs remains to be clarified. Moreover, in contrast to the established allosteric behavior of αE-cat, where β-catenin binding curiously limits αE-cat\'s capacity to bind actin filaments in solution,[@cit0029]^,^[@cit0030] αT-cat can bind cadherin/β-catenin and actin filaments, simultaneously.[@cit0031] Thus, while αE-cat within the cadherin/β-catenin complex shows preferential binding to actin filaments under tension,[@cit0026] αT-cat behaves as a constitutively active, actin-binding protein that can physically couple cadherin/β-catenin to actin in the absence of tension,[@cit0031] which may be relevant to αT-cat\'s unique junctional and tissue-specific role (see below). In addition to differences in actin-binding between αE- and αT-cat proteins, recruitment of ligand-binding partners through the M-domain also appears distinct, as loss of αE-cat in heart reduces vinculin recruitment to cardiac cell-cell junctions,[@cit0011] whereas loss of αT-cat reduces plakophilin-2 (PKP2) recruitment[@cit0015]^,^[@cit0032] (also below). Lastly, it is worth noting that all three α-catenins show a capacity to form homodimers *in vitro* that are incompatible with cadherin/β-catenin binding, and which allows for robust F-actin binding and bundling activity.[@cit0030]^,^[@cit0031]^,^[@cit0033]^,^[@cit0034] However, recently measured kinetic parameters suggest that only αE-cat may be able to sustain the homodimeric state at physiological concentration in cells,[@cit0033] where homodimerization contributes to membrane protrusive activities required for cell migration and nascent contact formation.[@cit0035]^,^[@cit0036] Together, these data suggest that mechanosensor, M-domain-binding-partner and homodimerization abilities of αT-cat are distinct from αE-cat, which may be relevant to the tissue-restricted functions of αT-cat.

αT-cat in the heart and cardiomyopathy {#s0001-0003}
--------------------------------------

αT-cat was named for its localization in peritubular myoid cells of the testis,[@cit0032] but is currently best known for its role in the heart. This is largely because αT-cat null mice show no obvious fertility defects, but rather develop a dilated cardiomyopathy (DCM) after 3--6 months of age.[@cit0015] Although mutations in αT-cat have not yet been found associated with DCM in humans,[@cit0037]^,^[@cit0038] two mutations (detailed below) have been implicated in the development of arrythmogenic right ventricle cardiomyopathy (ARVC).[@cit0039] As recent evidence indicates that the left ventricle is often affected in historically defined ARVC patients, this biventricular disease is now referred to as arrhythmogenic cardiomyopathy (ACM).[@cit0040]

ACM disease is typically caused by mutations in proteins that comprise desmosomes, a type of cadherin-based intercellular adhesion that employs plaque proteins (plakoglobin, plakophilins, desmoplakin) to link to the intermediate filament cytoskeleton.[@cit0041] Desmosomes are particularly important in tissues that withstand substantial mechanical strain, such as heart and skin.[@cit0042]^,^[@cit0043] In this regard, αT-cat prominently localizes to a specialized cell-cell junction in cardiomyocytes, known as the intercalated disc (ICD), which contains distinct adherens junction, desmosome and gap junction structures.[@cit0044]^,^[@cit0045] In the hearts of higher vertebrates, the ICD largely comprises a hybrid adherens junction/desmosome structure known as the *area composita*,[@cit0046]^,^[@cit0047] where this hybrid junction is considered optimized to withstand the increased mechanical load of the four-chamber mammalian heart.[@cit0048] Although the unique strength and molecular mechanics of this junction type remains poorly understood, αT-cat may be a key integrator of the *area composita*, as it directly binds the desmosome component plakophilin-2 (PKP2)[@cit0051] while also participating in the cadherin/β-catenin complex, presumably reinforcing adherens junction and desmosome alignment ([Fig. 4](#f0004){ref-type="fig"}). Indeed, while αT-cat knock-out hearts develop normally due to compensation by the related αE-cat, over time, these mice show reduced localization of PKP2 and the Connexin 43 gap junction component at intercalated disks.[@cit0015] Reduced *area composita*, hybrid-junction coupling (via PKP2) likely contributes to the decreased cardiac contractility and ejection fraction of αT-cat null mice, whereas reduced gap junction coupling (via Connexin 43) increases sensitivity to ventricular arrhythmia following ischemic injury.[@cit0015] Figure 4.Model of αT-cat in cardiomyocyte cell-cell adhesion. αT-cat (orange) can interact with β-cat, actin and the desmosomal component, PKP2, via its central M-domain (end of M2 and M3), which allows for the alignment and reinforcement of a hybrid adherens junction-desmosome structure known as the *area composita* region of the intercalated disk. The intermediate filament-binding protein, desmoplakin (DSP), is also shown.

Evidence that *PKP2* mutations are also associated with ACM,[@cit0052] suggest that a particular aspect of αT-cat/PKP2 coupling may be important for normal right ventricle structure and function. For example, PKP2 interacts with αT-cat (but not αE-cat) via the M-domain.[@cit0039]^,^[@cit0051] As discussed above, both αE-cat M- and actin-binding domains require force-dependent conformation regulatory events for their respective binding activities, whereas αT-cat appears less mechanosensitive, being more available to its binding-partners.[@cit0020]^,^[@cit0031] These or other differences may explain why αT-cat is dispensable for normal heart development (due to compensation by αE-cat), but important for cardiac function with age. Indeed, as the mechanical load on the heart increases after birth and the ICD matures, αT-cat\'s role as molecular integrator of the *area composita* appears critical, as evidenced by the earlier onset of cardiomyopathy in αT-cat mutant mice compared to αE-cat conditional KO mice (3 versus 8 months of age, respectively).[@cit0011]^,^[@cit0015]

Recent biochemical and cell culture studies now rationalize how αT-cat heterozygous mutations may function as dominant inhibitors of cardiomyocyte function in ACM: One mutation (V94D) blocks β-catenin binding[@cit0039] and favors αT-cat homodimerzation,[@cit0031] leading to altered junctional localization in cardiomyocyte junctions[@cit0031]; the second mutation deletes a leucine in the critical actin-binding domain (L765del) and induces protein dimerization/ aggregation.[@cit0031]^,^[@cit0039] Although formal evidence for these mutations causing ACM awaits testing in mouse models, it appears that both αT-cat pathogenic mutations enhance the intrinsic homodimerization and/or aggregation potential of αT-cat, which may prevent normal cadherin/catenin/actin coupling and other possible maladaptation. Lastly, it is worth noting that requirement of α-catenin-based cell-cell adhesion to heart structure and function is not absolute, but contextual, and based on developmental timing or degree of tissue injury. For example, the early loss of both αE- and αT-cat in mice is incompatible with heart development but tolerated when induced perinatally.[@cit0053] Remarkably, the loss of both catenins appears beneficial when removed in adult hearts subjected to ischemic injury, in part due to elevated YAP signaling that favors proliferation.[@cit0053] Such complexities raise the counterintuitive possibility that attenuating the function of proteins collectively required for tissue development may be beneficial during adult tissue repair after injury.

αT-cat linkages to allergic disease {#s0001-0004}
-----------------------------------

One of the more surprising developments in the α-catenin field are the number of independent genetic association studies linking αT-cat (*CTNNA3*) with asthma and food allergy. Genome-wide association studies have linked several non-coding *CTNNA3* polymorphisms with two distinct forms of asthma, occupational asthma induced by chemical exposure[@cit0054]^,^[@cit0055] and steroid resistant atopic asthma.[@cit0056]^,^[@cit0057] One study identified copy number deletions in *CTNNA3* associated with pediatric food allergy.[@cit0058] The surprise with these associations is that the restricted distribution of αT-cat expression in human tissues ([Fig. 2](#f0002){ref-type="fig"}, brain/peripheral nerve, heart, skeletal muscle and testis) suggests that either rare, contextually activated or non-canonical cell-types contribute to allergic disease.

Using the viable and fertile αT-cat knock-out mouse described above, our team has validated these αT-cat linkages to asthma using both chemical and house dust-mite models of asthma.[@cit0059]^,^[@cit0060] Curiously, full loss of αT-cat strongly suppresses airway hyperreactivity, a hallmark of asthma, but the αT-cat-expressing cell type that drives allergic airway responses remains to be determined. Remarkably, the only lung cells that obviously express αT-cat are cardiomyocytes that line the pulmonary vasculature.[@cit0060]^,^[@cit0061] However, anatomical differences in human versus rodent pulmonary veins, their proximity to airways and relative degree of cardiomyocyte ensheathment has raised doubt that cardiomyocytes are the αT-cat-expressing cell type that drives asthma.[@cit0061]^,^[@cit0062] An appealing cell-type to consider for linkages between an adhesion protein and allergic diseases are immune cells. Although low levels of αT-cat RNA have been detected in EBV-transformed peripheral blood cells and lymphoid cancer lines[@cit0054]^,^[@cit0056]^,^[@cit0058] (<https://www.proteinatlas.org/ENSG00000183230-CTNNA3/cell>), evidence for protein detection is generally lacking, with exception of one study suggesting that αT-cat may contribute to the upregulation of basophil-activation markers, CD203c and CD63.[@cit0058] Indeed, immune cells generally do not express cadherins or α-catenin adhesion components, but Th2-cytokines can robustly upregulate E-cadherin and αE-cat in dendritic cells and alternatively activated macrophages.[@cit0063] We find no evidence that αT-cat is upregulated under these same conditions (not shown). Thus, future work will be required to further validate and understand these intriguing connections between αT-cat and allergic disease.

αT-cat in the nervous system and disease {#s0001-0005}
----------------------------------------

Early studies documented αT-cat protein expression in brain,[@cit0003] but functional significance of this expression has lagged presumably because of difficulties interrogating behavioral defects in mice. Moreover, identification of αT-cat-expressing cell types in the brain has been somewhat limited by the lack of robust tools (e.g., fluorescent membrane-anchored reporter mouse). For example, while an early study suggested that αT-cat protein may be expressed in murine cortical neurons,[@cit0068] αT-cat is more prominently detected in ependymal cell junctions that line ventricles, as well as cells within the molecular layer of the cerebellum.[@cit0069] In human tissue, RNA sequencing data reveal that αT-cat expression is highest in brain and spinal cord ([Fig. 2](#f0002){ref-type="fig"}), the latter of which is likely due to the presence of a central canal lined by αT-cat-positive ependymal cells. The unique functional role of αT-cat in this specialized epithelium remains unclear, however, as αT-cat knock-out mice show no obvious defect in ventricle structure, possibly due to compensatory upregulation of αE-cat.[@cit0069]

Despite the absence of an obvious neurological phenotype in αT-cat null mice (Frans Van Roy, personal communication), a number of linkage studies raise the possibility that αT-cat may contribute to disease in humans. Specifically, the αT-cat gene, *CTNNA3*, is located near a common fragile site on chromosome 10,[@cit0070] and has been linked to late onset Alzheimer\'s disease in females[@cit0071] (reviewed in[@cit0072]). *CTNNA3* is also linked to autism in two large cohorts of European ancestry with replication in two other cohorts,[@cit0073] and rare deletions in αT-cat were identified in individuals with autism spectrum disorder.[@cit0074]^,^[@cit0075] While transcriptomic analysis of WT and αT-cat knock-mouse cerebella suggest alteration of pathways linked to Alzheimer\'s and autism,[@cit0069] future work will be required to define the cell type and unique junctional-specialization supported by αT-cat function. Indeed, available online transcriptomic datasets of human and mouse brain cell populations suggest that oligodendrocytes may be a major αT-cat-expressing cell type in brain.[@cit0076]

αT-cat associations with cancer {#s0001-0006}
-------------------------------

Among the α-catenin family members, αE-cat is best appreciated for playing a contributing role in tumorigenesis in large part because it plays an integral part in epithelial cell-cell adhesion with E-cadherin (*CDH1*), a bona fide tumor-suppressor gene.[@cit0077]^,^[@cit0078] Since αT-cat mRNA and protein are generally absent from epithelial tissues ([Fig. 2](#f0002){ref-type="fig"}; see also Human Atlas), there was an early expectation that it might not contribute to cancer. However, a number of recent studies suggest that we may need to keep an open mind on this front. For example, a recent proximity proteomics study revealed αT-cat as the 9^th^ most abundant protein at E-cadherin contacts in non-transformed Madin Darby Canine Kidney epithelial cells,[@cit0079] raising the possibility that low levels of αT-cat mRNA may be uncorrelated from its polypeptide abundance. Remarkably, *CTNNA3* is one of the largest genes in the genome (i.e., spanning 1.78 Megabases) and proximal to a common fragile site (FRAD10D).[@cit0080] In this regard, monoallelic or reduced expression of *CTNNA3* is associated with urothelial carcinoma of the bladder,[@cit0081] pancreatic cancer associated with Schwachman-Diamond Syndrome,[@cit0082] oropharyngeal squamous cell carcinoma[@cit0083] and hepatocellular carcinoma.[@cit0084] In addition, deletion, truncation and missense mutations were identified in *CTNNA3* in NSCLCs[@cit0085] and laryngeal carcinoma.[@cit0086] In some of these studies, αT-cat was knocked-down and phenotypes typically associated with cancer were modestly enhanced (e.g., proliferation, invasion, migration).[@cit0084]^,^[@cit0086] Intriguingly, SNPs in *CTNNA3* were associated with radiation induced brain cancers[@cit0087] and focal loss of *CTNNA3* was associated with a hybrid neurofibroma/ schwannoma,[@cit0088] perhaps consistent with the prominent expression of *CTNNA3* in brain and peripheral nerve ([Fig. 2](#f0002){ref-type="fig"}). While these studies are suggestive, future work that makes use of validated, isoform-specific αT-cat antibodies and αT-cat knock-out/floxed mice[@cit0015]^,^[@cit0053] will be required to determine the extent to which αT-cat is a *bona fide* tumor suppressor protein, particularly since the relationship between cell-cell adhesion and cancer is not universally suppressive.[@cit0089]

Revised evolutionary perspective {#s0002}
================================

Comparison of the three α-catenin genes reveals that αT-cat is the most recently evolved, likely arising from an amniote-specific duplication of the αN-cat gene.[@cit0090] Evidence that αT-cat emerged with the development of terrestrial vertebrates that have a four-chambered heart, together with it being linked to ACM disease and required for normal cardiac function during murine lifespan, has led to the notion that αT-cat evolved to address the unique mechanical demands of the heart.[@cit0015]^,^[@cit0031]^,^[@cit0039] However, recent transcriptomic studies reveal that αT-cat is also abundantly expressed in the nervous system ([Fig. 2](#f0002){ref-type="fig"}).[@cit0076] This not only strengthens the plausibility of recent genetic linkages between αT-cat and neurological diseases,[@cit0069] but suggests that αT-cat evolved to meet the demands of two very different tissue systems (i.e., brain/peripheral nerves and heart). The mechano-organizational features that αT-cat uniquely brings to adherens junctions across these systems will require further study. Thus, while most of α-catenin research has focused on the developmentally essential founding member, αE-cat, the developmentally dispensable αT-cat may be worthy of greater attention, emerging as a broadly disease-relevant α-catenin.
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